These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32292572)

  • 1. A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy.
    Kumar NB; Pow-Sang J; Spiess P; Dickinson S; Schell MJ
    Oncotarget; 2020 Apr; 11(14):1218-1234. PubMed ID: 32292572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.
    Kumar NB; Kang L; Pow-Sang J; Xu P; Allen K; Riccardi D; Besterman-Dahan K; Krischer JP
    J Soc Integr Oncol; 2010; 8(1):3-13. PubMed ID: 20205984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.
    Kumar NB; Krischer JP; Allen K; Riccardi D; Besterman-Dahan K; Salup R; Kang L; Xu P; Pow-Sang J
    Nutr Cancer; 2007; 59(2):163-8. PubMed ID: 18001210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D
    Jarrard D; Konety B; Huang W; Downs T; Kolesar J; Kim KM; Havighurst T; Slaton J; House MG; Parnes HL; Bailey HH
    Am J Clin Exp Urol; 2016; 4(2):17-27. PubMed ID: 27766277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
    van Die MD; Bone KM; Williams SG; Pirotta MV
    BJU Int; 2014 May; 113(5b):E119-30. PubMed ID: 24053483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
    Vrieling A; Rookus MA; Kampman E; Bonfrer JM; Bosma A; Cats A; van Doorn J; Korse CM; Witteman BJ; van Leeuwen FE; van't Veer LJ; Voskuil DW
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2585-93. PubMed ID: 18842999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specific role of isoflavones in reducing prostate cancer risk.
    Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
    Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.
    Kumar NB; Besterman-Dahan K; Kang L; Pow-Sang J; Xu P; Allen K; Riccardi D; Krischer JP
    Clin Med Urol; 2008 Apr; 1():1-14. PubMed ID: 20354574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.
    Ahn-Jarvis JH; Clinton SK; Grainger EM; Riedl KM; Schwartz SJ; Lee ML; Cruz-Cano R; Young GS; Lesinski GB; Vodovotz Y
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1045-54. PubMed ID: 26276749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.
    Kumar N; Crocker T; Smith T; Pow-Sang J; Spiess PE; Connors S; Chornukur G; Dickinson SI; Bai W; Williams CR; Salup R; Fu W
    J Cancer Sci Ther; 2012; 2011(S3):. PubMed ID: 22422102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
    Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
    Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
    Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.
    Adams KF; Chen C; Newton KM; Potter JD; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):644-8. PubMed ID: 15066931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings.
    Student V; Vidlar A; Bouchal J; Vrbkova J; Kolar Z; Kral M; Kosina P; Vostalova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):559-565. PubMed ID: 27833172
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.